The “German Unity Day” Forum was successfully held at Chongqing Raffles InterContinental Hotel. Aron Mir Haschemi, Consul General of Germany in Chengdu, Dr. Stephan Keller, Mayor of Düsseldorf, Germany, and others attended the event. Officially invited by the German government, HymonBio was the only specially invited company to share its innovative products at this event.
At the forum, Dr. Tammy Tan introduced the latest technological achievement of her company—the Pan-Cancer Screening Test Kit. HymonBio’s team uses their own patented technology to combine artificial intelligence with life sciences. 28 common cancers can be detected with just one tube of blood. The use of intelligent AI algorithms makes pan-tumor detection analysis easier.
At present, this product is the first of its kind in the world. The only product that can compete with it in the world is the pan-cancer detection product of Grail in the United States, with a price of 10,000 US dollars. The successful development of HymonBio’s pan-tumor screening product has broken the global monopoly of Grail, allowing Chinese people to enjoy the health check-up service at a price of 350 US dollars.
With the popularization of PCR instruments in my country, HymonBio’s pan-cancer screening kit can be widely used in almost all medical institutions including grassroots county hospitals, becoming the closest pan-cancer screening program for Chinese people.
Exhibition Preview
Looking back, the relationship between HymonBio and Germany originated from the MEDICA exhibition. It is worth mentioning that this year the German government attached great importance to this exhibition and specially adjusted our booth to Hall 1. This move undoubtedly demonstrates the important position of HymonBio in the industry and the recognition and support of the German government for us. Let’s meet together at this year’s Medica Hall 1, see you there!
Post time: Oct-25-2024